Renal transplant rejection
Information
- Disease name
- Renal transplant rejection
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04530630 | Active, not recruiting | Phase 4 | Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide After Renal Transplant | November 9, 2020 | September 2024 |
| NCT03719339 | Active, not recruiting | VIRTUUS Children's Study | August 10, 2017 | May 31, 2024 | |
| NCT03511560 | Active, not recruiting | Phase 4 | Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation | July 26, 2018 | July 2021 |
| NCT00866879 | Completed | Phase 4 | Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients | June 2007 | March 2019 |
| NCT01239472 | Completed | Phase 4 | Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant | January 2011 | June 2015 |
| NCT00658073 | Completed | N/A | Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts | March 2008 | October 2010 |
| NCT00695097 | Completed | N/A | The Effect of Rituximab on the Development of Anti-Donor Antibodies | August 2004 | December 2010 |
| NCT00771745 | Completed | Phase 4 | Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients | September 2008 | July 2010 |
| NCT01953120 | Completed | Phase 4 | Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) | October 2013 | April 21, 2021 |
| NCT02006108 | Completed | N/A | Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance | November 27, 2012 | April 11, 2017 |
| NCT02284464 | Completed | Phase 4 | Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients | February 2015 | December 2019 |
| NCT02377193 | Completed | Phase 4 | Simulect Versus ATG in Sensitized Renal Transplant Patient | September 2013 | January 2017 |
| NCT02500251 | Completed | Phase 1/Phase 2 | Belimumab Impacting Transplant Eligibility | June 2015 | August 2018 |
| NCT02581436 | Completed | N/A | Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR | September 2014 | February 1, 2018 |
| NCT02733029 | Completed | Phase 2 | Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection | May 30, 2018 | February 1, 2023 |
| NCT02866682 | Completed | Phase 4 | Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients | March 1, 2018 | June 11, 2021 |
| NCT03140514 | Completed | N/A | Urine CXCL10 Chemokine Monitoring Post-renal Transplant | September 28, 2017 | July 15, 2022 |
| NCT03512431 | Completed | Dose Adjustment of Tacrolimus Based on Home Sampling in Renal Transplant Recipients | April 4, 2018 | November 1, 2018 | |
| NCT04114188 | Completed | Phase 2 | Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI) | December 15, 2016 | December 31, 2020 |
| NCT05385432 | Not yet recruiting | Phase 3 | Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies | September 12, 2023 | March 1, 2030 |
| NCT06438107 | Not yet recruiting | Deep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes | June 2024 | December 2029 | |
| NCT03192007 | Not yet recruiting | Multi-Parametric MRI for Renal Transplantation | July 1, 2024 | December 31, 2025 | |
| NCT05756036 | Recruiting | Torque Teno Virus: A Biomarker of Immunosuppression | February 15, 2022 | March 31, 2026 | |
| NCT03422224 | Recruiting | ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation | July 1, 2017 | July 2024 | |
| NCT03991780 | Recruiting | Phase 1/Phase 2 | Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection | May 8, 2019 | July 31, 2024 |
| NCT03707262 | Recruiting | Phase 1/Phase 2 | Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor | November 6, 2019 | February 2025 |
| NCT00983645 | Terminated | Phase 4 | A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity | October 2004 | March 2013 |
| NCT01413685 | Terminated | Phase 4 | Calcineurin Activity in Renal Recipients | January 2009 | July 2010 |
| NCT03646344 | Terminated | Phase 3 | Heme Arginate in Transplantation Study | March 12, 2019 | February 23, 2021 |
| NCT01324934 | Terminated | Phase 3 | Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids | October 2006 | January 2011 |
| NCT03780101 | Terminated | Pathology and Imaging in Kidney Allografts | February 15, 2019 | May 24, 2022 | |
| NCT02409940 | Unknown status | Phase 1 | To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients | September 2013 | March 2017 |
| NCT02490020 | Unknown status | Phase 1 | A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death | January 2016 | December 2018 |
| NCT03705091 | Unknown status | MRI in Renal Transplantation | April 11, 2017 | March 20, 2019 | |
| NCT02057965 | Unknown status | Phase 2 | Mesenchymal Stromal Cell Therapy in Renal Recipients | March 2014 | January 2022 |
| NCT01631058 | Unknown status | Phase 4 | Renal Transplantation in the Elderly - nEverOld Study | July 2012 | June 2019 |
| NCT05073822 | Withdrawn | Phase 1/Phase 2 | NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation | February 20, 2023 | February 20, 2027 |